279220-35-8

Basic information

• Product Name: {9-[4-(3,5-dimethyl-benzyl)-5-ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-ylcarbamoyl]-nonyl}-carbamic acid tert-butyl ester
• Synonyms: {9-[4-(3,5-dimethyl-benzyl)-5-ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-ylcarbamoyl]-nonyl}-carbamic acid tert-butyl ester
• CAS NO: 279220-35-8
• Molecular Weight: 539.759
• Mol File: 279220-35-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: {9-[4-(3,5-dimethyl-benzyl)-5-ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-ylcarbamoyl]-nonyl}-carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: {9-[4-(3,5-dimethyl-benzyl)-5-ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-ylcarbamoyl]-nonyl}-carbamic acid tert-butyl ester(279220-35-8)
• EPA Substance Registry System: {9-[4-(3,5-dimethyl-benzyl)-5-ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-ylcarbamoyl]-nonyl}-carbamic acid tert-butyl ester(279220-35-8)

Safety Data

• Hazardous Substances Data: 279220-35-8(Hazardous Substances Data)

Upstream product

• 173606-50-3 10-(N-tert-butoxycarbonyl)aminodecanoic acid 
• 248246-95-9 3-amino-4-(3,5-dimethylbenzyl)-5-ethyl-6-methylpyridin-2(1H)-one 

Downstream Products

• 279220-39-2 10-amino-decanoic acid [4-(3,5-dimethyl-benzyl)-5-ethyl-6-methyl-2-oxo-1,2-dihydro-pyridin-3-yl]-amide 

Relevant articles and documents

Synthesis and evaluation of 'AZT-HEPT', 'AZT-pyridinone', and 'ddC-HEPT' conjugates as inhibitors of HIV reverse transcriptase

To test the concept that HIV reverse transcriptase could be effectively inhibited by 'mixed site inhibitors', a series of seven conjugates containing both a nucleoside analogue component (AZT 1, ddC 2) and a nonnucleoside type inhibitor (HEPT analogue 12,